A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/40 (2006.01) A61K 31/4985 (2006.01) A61P 3/00 (2006.01) A61P 9/00 (2006.01)
Patent
CA 2756786
The present invention relates to methods for preventing or reducing the risk of mortality by any means including, but not limited to, cardiovascular events in mammals, particularly humans, comprising administering a dipeptidyl peptidase 4 (DPP-IV) inhibitor to the mammal or human. In addition, the present invention relates to methods for preventing or reducing the risk of non- fatal myocardial infarction and/or non- fatal stroke in mammals, particularly humans, comprising administering a DPP-IV inhibitor to the mammal or human.
La présente invention concerne des procédés destinés à prévenir ou à réduire le risque de mortalité liée à des événements comprenant, mais non limités à, des événements cardiovasculaires chez les mammifères, en particulier les humains, comprenant l'étape consistant à administrer un inhibiteur de la dipeptidyl-peptidase 4 (DPP-IV) au mammifère ou humain. De plus, la présente invention concerne des procédés destinés à prévenir ou à réduire le risque d'un infarctus du myocarde non-fatal et/ou d'un accident vasculaire cérébral non-fatal chez des mammifères, en particulier les humains, comprenant l'étape consistant à administrer un inhibiteur de la DPP-IV au mammifère ou humain.
Edelberg Jay
Fiedorek Fred
Frederich Robert
Astrazeneca Uk Limited
Bristol-Myers Squibb Company
Gowling Lafleur Henderson Llp
LandOfFree
Methods for preventing major adverse cardiovascular events... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for preventing major adverse cardiovascular events..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for preventing major adverse cardiovascular events... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1631780